Sunitinib plus androgen deprivation and radiation therapy for patients with localized high-risk prostate cancer: results from a multi-institutional phase 1 study.

Sunitinib plus androgen deprivation and radiation therapy for patients with localized high-risk prostate cancer: results from a multi-institutional phase 1 study.

Item
http://www.wikidata.org/entity/Q33918464
Combining radiotherapy with sunitinib: lessons (to be) learnedCombining targeted agents with modern radiotherapy in soft tissue sarcomas.A phase II study of GW786034 (pazopanib) with or without bicalutamide in patients with castration-resistant prostate cancerMolecularly targeted agents as radiosensitizers in cancer therapy--focus on prostate cancer.Low dose angiostatic treatment counteracts radiotherapy-induced tumor perfusion and enhances the anti-tumor effect.Targeting the relaxin hormonal pathway in prostate cancer.Pleural synovial sarcoma patient treated with combined chemotherapy and Endostar, plus sunitinib maintenance therapy: A case report and review of the literature.Sunitinib reduces tumor hypoxia and angiogenesis, and radiosensitizes prostate cancer stem-like cells.Optimal treatment scheduling of ionizing radiation and sunitinib improves the antitumor activity and allows dose reductionExploiting radiation-induced signaling to increase the susceptibility of resistant cancer cells to targeted drugs: AKT and mTOR inhibitors as an example.
P2860

Sunitinib plus androgen deprivation and radiation therapy for patients with localized high-risk prostate cancer: results from a multi-institutional phase 1 study.

Item
http://www.wikidata.org/entity/Q33918464
description
2013 nî lūn-bûn
@nan
2013 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մարտին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
name
Sunitinib plus androgen depriv ...... i-institutional phase 1 study.
@ast
Sunitinib plus androgen depriv ...... i-institutional phase 1 study.
@en
type
label
Sunitinib plus androgen depriv ...... i-institutional phase 1 study.
@ast
Sunitinib plus androgen depriv ...... i-institutional phase 1 study.
@en
prefLabel
Sunitinib plus androgen depriv ...... i-institutional phase 1 study.
@ast
Sunitinib plus androgen depriv ...... i-institutional phase 1 study.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P921
P932
P356
P1433
P1476
Sunitinib plus androgen depriv ...... i-institutional phase 1 study.
@en
P2093
P2860
P304
P31
P356
10.1016/J.IJROBP.2012.12.029
P407
P433
P478
P577
P698
P921
P932